Although small-cell lung cancer (SCLC) represents only 20% of all lung cancer cases in the United States, it is the most lethal subtype. Combination chemotherapy unequivocally offers the best chance for improved survival in
Daniel C. Ihde, MD
Advertisement
Articles by Daniel C. Ihde, MD
Advertisement
Latest Updated Articles
- Small-Cell Lung Cancer: Treatment Progress and Prospects
Published: May 1st 1998 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
2
Forming CUTNETs: A Joint Venture Between Surgery and Oncology in NETs
3
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
4
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
5
